Search research articles
Contact Us
Filters
Showing results (81-90 of 94) with videos related to
Page
of 10
Sort By:
Angewandte Chemie (International Ed. in English)
|
November 18, 2021
Inhibitor-Mediated Structural Transition in a Minimal Amyloid Model
Priyadarshi Chakraborty, Santu Bera, Phil Mickel, et al.
Urology
|
January 9, 2021
Urology Residency Training in Medically Underserved Areas Through the Integration of a Federally Qualified Health Center Rotation
Juan F Javier-DesLoges, Daniel Segal, Amir Khan, et al.
Cellular and Molecular Life Sciences : CMLS
|
September 14, 2020
Differential effects of putative N-glycosylation sites in human Tau on Alzheimer's disease-related neurodegeneration
Yelena Losev, Moran Frenkel-Pinter, Malak Abu-Hussien, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 17, 2002
Ssdp proteins interact with the LIM-domain-binding protein Ldb1 to regulate development
Lan Chen, Daniel Segal, Neil A Hukriede, et al.
Molecular Systems Biology
|
May 9, 2007
Genomic analysis of COP9 signalosome function in Drosophila melanogaster reveals a role in temporal regulation of gene expression
Efrat Oron, Tamir Tuller, Ling Li, et al.
Chemical Communications (Cambridge, England)
|
November 21, 2019
Tryptophan-glucosamine conjugates modulate tau-derived PHF6 aggregation at low concentrations
Ashim Paul, Wen-Hao Li, Guru KrishnaKumar Viswanathan, et al.
ACS Nano
|
September 10, 2025
Correction to "Self-Assembly of Accumulated Sphingolipids into Cytotoxic Fibrils in Globoid Cell Leukodystrophy and Their Inhibition by Small Molecules in Vitro"
Sourav Kumar, Evelina Nikelshparg, Jana Pilátová, et al.
Neurobiology of Aging
|
May 30, 2017
Altered protein glycosylation predicts Alzheimer's disease and modulates its pathology in disease model Drosophila
Moran Frenkel-Pinter, Shiri Stempler, Sharon Tal-Mazaki, et al.
The Journal of Biological Chemistry
|
May 3, 2013
A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD)
Ronit Shaltiel-Karyo, Moran Frenkel-Pinter, Edward Rockenstein, et al.
Plos One
|
February 10, 2011
Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models
Anat Frydman-Marom, Aviad Levin, Dorit Farfara, et al.
Page
of 10
Search research articles
Search
Showing results (81-90 of 94) with videos related to
Sort By:
Page
of 10
Angewandte Chemie (International Ed. in English)
|
November 18, 2021
Inhibitor-Mediated Structural Transition in a Minimal Amyloid Model
Priyadarshi Chakraborty, Santu Bera, Phil Mickel, et al.
Urology
|
January 9, 2021
Urology Residency Training in Medically Underserved Areas Through the Integration of a Federally Qualified Health Center Rotation
Juan F Javier-DesLoges, Daniel Segal, Amir Khan, et al.
Cellular and Molecular Life Sciences : CMLS
|
September 14, 2020
Differential effects of putative N-glycosylation sites in human Tau on Alzheimer's disease-related neurodegeneration
Yelena Losev, Moran Frenkel-Pinter, Malak Abu-Hussien, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 17, 2002
Ssdp proteins interact with the LIM-domain-binding protein Ldb1 to regulate development
Lan Chen, Daniel Segal, Neil A Hukriede, et al.
Molecular Systems Biology
|
May 9, 2007
Genomic analysis of COP9 signalosome function in Drosophila melanogaster reveals a role in temporal regulation of gene expression
Efrat Oron, Tamir Tuller, Ling Li, et al.
Chemical Communications (Cambridge, England)
|
November 21, 2019
Tryptophan-glucosamine conjugates modulate tau-derived PHF6 aggregation at low concentrations
Ashim Paul, Wen-Hao Li, Guru KrishnaKumar Viswanathan, et al.
ACS Nano
|
September 10, 2025
Correction to "Self-Assembly of Accumulated Sphingolipids into Cytotoxic Fibrils in Globoid Cell Leukodystrophy and Their Inhibition by Small Molecules in Vitro"
Sourav Kumar, Evelina Nikelshparg, Jana Pilátová, et al.
Neurobiology of Aging
|
May 30, 2017
Altered protein glycosylation predicts Alzheimer's disease and modulates its pathology in disease model Drosophila
Moran Frenkel-Pinter, Shiri Stempler, Sharon Tal-Mazaki, et al.
The Journal of Biological Chemistry
|
May 3, 2013
A blood-brain barrier (BBB) disrupter is also a potent α-synuclein (α-syn) aggregation inhibitor: a novel dual mechanism of mannitol for the treatment of Parkinson disease (PD)
Ronit Shaltiel-Karyo, Moran Frenkel-Pinter, Edward Rockenstein, et al.
Plos One
|
February 10, 2011
Orally administrated cinnamon extract reduces β-amyloid oligomerization and corrects cognitive impairment in Alzheimer's disease animal models
Anat Frydman-Marom, Aviad Levin, Dorit Farfara, et al.
Page
of 10